Jim Hindman
Director/Board Member at Urovant Sciences, Inc.
Profile
Jim Hindman is currently a Director at Urovant Sciences, Inc. since 2020.
Prior to this, he worked as the Chief Operating Officer at Seaside National Bank & Trust.
Jim Hindman active positions
| Companies | Position | Start |
|---|---|---|
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Director/Board Member | 2020-04-30 |
Former positions of Jim Hindman
| Companies | Position | End |
|---|---|---|
Seaside National Bank & Trust
 Seaside National Bank & Trust Major BanksFinance Seaside National Bank & Trust is a nationally-chartered commercial bank that offers its clients a complete array of wealth management, commercial and private banking financial solutions. The company was founded by Gideon T. Haymaker on October 31, 2006 and is headquartered in Orlando, FL. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Seaside National Bank & Trust
Seaside National Bank & Trust Major BanksFinance Seaside National Bank & Trust is a nationally-chartered commercial bank that offers its clients a complete array of wealth management, commercial and private banking financial solutions. The company was founded by Gideon T. Haymaker on October 31, 2006 and is headquartered in Orlando, FL. | Finance |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Stock Market
- Insiders
- Jim Hindman
